
### [NCIT:C68686](http://purl.obolibrary.org/obo/NCIT_C68686)
**Label:** Stage II Aggressive Adult Non-Hodgkin Lymphoma

**Subclasses:** [NCIT:C8126](http://purl.obolibrary.org/obo/NCIT_C8126) (Stage II Adult Burkitt Lymphoma), [NCIT:C8125](http://purl.obolibrary.org/obo/NCIT_C8125) (Stage II Adult Lymphoblastic Lymphoma), 

**Class expressions from DL-Learner:**

- [NCIT:C28054](http://purl.obolibrary.org/obo/NCIT_C28054) (Stage II) 53.85%
- Thing 52.89%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38174](http://purl.obolibrary.org/obo/NCIT_C38174) (IRF4/MUM1 Messenger RNA Overexpression))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38173](http://purl.obolibrary.org/obo/NCIT_C38173) (BCL2 Gene mRNA Overexpression))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38172](http://purl.obolibrary.org/obo/NCIT_C38172) (Cyclin D2 Messenger RNA Overexpression))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38171](http://purl.obolibrary.org/obo/NCIT_C38171) (PKCbeta1 Messenger RNA Overexpression))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38170](http://purl.obolibrary.org/obo/NCIT_C38170) (LMO2 Messenger RNA Overexpression))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38169](http://purl.obolibrary.org/obo/NCIT_C38169) (A-myb Messenger RNA Overexpression))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38168](http://purl.obolibrary.org/obo/NCIT_C38168) (BCL-6 Messenger RNA Overexpression))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38167](http://purl.obolibrary.org/obo/NCIT_C38167) (CD10 Messenger RNA Overexpression))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38158](http://purl.obolibrary.org/obo/NCIT_C38158) (Metachronous Wilms Tumor))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38157](http://purl.obolibrary.org/obo/NCIT_C38157) (Metachronous Osteosarcoma))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38155](http://purl.obolibrary.org/obo/NCIT_C38155) (Recurrent Disease))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38111](http://purl.obolibrary.org/obo/NCIT_C38111) (Skin Sarcomatoid Basal Cell Carcinoma))) 39.20%


